122 related articles for article (PubMed ID: 16595372)
21. The International HIV Dementia Scale: a new rapid screening test for HIV dementia.
Sacktor NC; Wong M; Nakasujja N; Skolasky RL; Selnes OA; Musisi S; Robertson K; McArthur JC; Ronald A; Katabira E
AIDS; 2005 Sep; 19(13):1367-74. PubMed ID: 16103767
[TBL] [Abstract][Full Text] [Related]
22. Prevalence, characteristics and correlates of a positive-dementia screen in patients on antiretroviral therapy in Bamenda, Cameroon: a cross-sectional study.
Atashili J; Gaynes BN; Pence BW; Tayong G; Kats D; O'donnell JK; Ndumbe PM; Njamnshi AK
BMC Neurol; 2013 Jul; 13():86. PubMed ID: 23855622
[TBL] [Abstract][Full Text] [Related]
23. Reliability of the lay adherence counsellor administered substance abuse and mental illness symptoms screener (SAMISS) and the International HIV Dementia Scale (IHDS) in a primary care HIV clinic in Cape Town, South Africa.
Breuer E; Stoloff K; Myer L; Seedat S; Stein DJ; Joska J
AIDS Behav; 2012 Aug; 16(6):1464-71. PubMed ID: 22001934
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: results from an urban observational cohort.
Tozzi V; Balestra P; Lorenzini P; Bellagamba R; Galgani S; Corpolongo A; Vlassi C; Larussa D; Zaccarelli M; Noto P; Visco-Comandini U; Giulianelli M; Ippolito G; Antinori A; Narciso P
J Neurovirol; 2005 Jul; 11(3):265-73. PubMed ID: 16036806
[TBL] [Abstract][Full Text] [Related]
25. HIV-1 effects on neuropsychological performance in a resource-limited country, Zambia.
Holguin A; Banda M; Willen EJ; Malama C; Chiyenu KO; Mudenda VC; Wood C
AIDS Behav; 2011 Nov; 15(8):1895-901. PubMed ID: 21744118
[TBL] [Abstract][Full Text] [Related]
26. Epidemiology and predictive factors for chemokine receptor use in HIV-1 infection.
Moyle GJ; Wildfire A; Mandalia S; Mayer H; Goodrich J; Whitcomb J; Gazzard BG
J Infect Dis; 2005 Mar; 191(6):866-72. PubMed ID: 15717260
[TBL] [Abstract][Full Text] [Related]
27. HIV-1 chemokine coreceptor utilization in paired cerebrospinal fluid and plasma samples: a survey of subjects with viremia.
Spudich SS; Huang W; Nilsson AC; Petropoulos CJ; Liegler TJ; Whitcomb JM; Price RW
J Infect Dis; 2005 Mar; 191(6):890-8. PubMed ID: 15717264
[TBL] [Abstract][Full Text] [Related]
28. Comparison of two screening tests for HIV-Associated Neurocognitive Disorder suspected Japanese patients with respect to cART usage.
Kami-Onaga K; Tateyama M; Kinjo T; Parrott G; Tominaga D; Takahashi-Nakazato A; Nakamura H; Tasato D; Miyagi K; Maeda S; Arae H; Uehara H; Miyagi K; Haranaga S; Fujita J
PLoS One; 2018; 13(6):e0199106. PubMed ID: 29902251
[TBL] [Abstract][Full Text] [Related]
29. The effects of antiretroviral treatment initiation on cognition in HIV-infected individuals with advanced disease in Pune, India.
Ghate M; Mehendale S; Meyer R; Umlauf A; Deutsch R; Kamat R; Thakar M; Risbud A; Kulkarni S; Sakamoto M; Alexander T; Franklin D; Letendre S; Heaton RK; Grant I; Marcotte TD
J Neurovirol; 2015 Aug; 21(4):391-8. PubMed ID: 25750072
[TBL] [Abstract][Full Text] [Related]
30. Adding a brief self-report cognitive tool to the IHDS improves effectiveness of identifying patients with HIV-associated dementia in South Africa.
Gouse H; Casson-Crook M; Decloedt EH; Joska JA; Thomas KGF
J Neurovirol; 2017 Oct; 23(5):686-695. PubMed ID: 28748448
[TBL] [Abstract][Full Text] [Related]
31. Cognitive Function among HIV Infected Children in Pune.
Ghate M; Narkhede H; Rahane G; Nirmalkar A; Gaikwad N; Kadam D
Indian J Pediatr; 2015 Jun; 82(6):515-8. PubMed ID: 25432090
[TBL] [Abstract][Full Text] [Related]
32. Human immunodeficiency virus dementia patients in Africa: How many? Who cares? And where to from here?
Birbeck GL
J Neurovirol; 2005; 11 Suppl 3():30-3. PubMed ID: 16540452
[TBL] [Abstract][Full Text] [Related]
33. [Natural history of human immunodeficiency virus infection in a cohort of Chilean patients].
Vial PA; Ferreccio C; Abarca K; Ortiz E; Noriega M; Pérez C; Labarca J; Torres M; Ferrés M; González C; Acuña G
Rev Med Chil; 1996 May; 124(5):525-35. PubMed ID: 9035503
[TBL] [Abstract][Full Text] [Related]
34. Nadir CD4 cell count predicts neurocognitive impairment in HIV-infected patients.
Muñoz-Moreno JA; Fumaz CR; Ferrer MJ; Prats A; Negredo E; Garolera M; Pérez-Alvarez N; Moltó J; Gómez G; Clotet B
AIDS Res Hum Retroviruses; 2008 Oct; 24(10):1301-7. PubMed ID: 18844464
[TBL] [Abstract][Full Text] [Related]
35. Profile of central nervous system disease in HIV/AIDS patients with special reference to cryptococcal infections.
Wadhwa A; Kaur R; Bhalla P
Neurologist; 2008 Jul; 14(4):247-51. PubMed ID: 18617851
[TBL] [Abstract][Full Text] [Related]
36. Oropharyngeal candidiasis and Candida colonization in HIV positive patients in northern India.
Maurya V; Srivastava A; Mishra J; Gaind R; Marak RS; Tripathi AK; Singh M; Venkatesh V
J Infect Dev Ctries; 2013 Aug; 7(8):608-13. PubMed ID: 23949296
[TBL] [Abstract][Full Text] [Related]
37. Predictors of symptomatic HIV-associated neurocognitive disorders in universal health care.
McCombe JA; Vivithanaporn P; Gill MJ; Power C
HIV Med; 2013 Feb; 14(2):99-107. PubMed ID: 22994556
[TBL] [Abstract][Full Text] [Related]
38. Human immunodeficiency virus type 1 clade A and D neurotropism: molecular evolution, recombination, and coreceptor use.
Zhang K; Hawken M; Rana F; Welte FJ; Gartner S; Goldsmith MA; Power C
Virology; 2001 Apr; 283(1):19-30. PubMed ID: 11312658
[TBL] [Abstract][Full Text] [Related]
39. Characterization of GBV-C infection in HIV-1 infected patients.
Canducci F; Uberti Foppa C; Boeri E; Racca S; Gallotta G; Grasso MA; Calori G; Lazzarin A; Clementi M
J Biol Regul Homeost Agents; 2003; 17(2):191-4. PubMed ID: 14518722
[TBL] [Abstract][Full Text] [Related]
40. Polymorphism in the CCR5 gene promoter and HIV-1 infection in North Indians.
Kaur G; Singh P; Rapthap CC; Kumar N; Vajpayee M; Sharma SK; Wanchu A; Mehra NK
Hum Immunol; 2007 May; 68(5):454-61. PubMed ID: 17462514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
